Q4 2015 · 10-K
Revenue$30.72M$30.72M −8.3% vs Q4 2014+7.3% vs Q3 2015
Net Income-$12.88M-$12.88M derivedN/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.45-$0.45 N/M vs Q4 2014N/M vs Q3 2015
Operating Incomederived-$13,692,000N/M
Operating Cash Flowderived-$4,404,000N/M
Free Cash Flowderived-$5,841,000N/M
Margins · derived
Operating margin-44.6%−15.2 pt vs Q4 2014
Net margin-41.9%−9.2 pt vs Q4 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $30.72M | $33.49M | $20.88M | $15.66M |
| Net Income | -$12.88M | -$10.94M | -$4.64M | -$3.60M |
| EPS Diluted | -$0.45 | -$0.39 | -$0.18 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR